Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

PD-1 blockade is effective for only a subset of patients with cutaneous T cell lymphomas. Here, the authors report a spatial biomarker that uses immune and cancer cell topography to predict response to PD-1 blockade in this disease.

Guardado en:
Detalles Bibliográficos
Autores principales: Darci Phillips, Magdalena Matusiak, Belén Rivero Gutierrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang, Janos Demeter, Kimberly S. Smythe, Robert H. Pierce, Steven P. Fling, Nirasha Ramchurren, Martin A. Cheever, Yury Goltsev, Robert B. West, Michael S. Khodadoust, Youn H. Kim, Christian M. Schürch, Garry P. Nolan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/185b95b3ae0241efb2f75ef0ed8fba8c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:185b95b3ae0241efb2f75ef0ed8fba8c
record_format dspace
spelling oai:doaj.org-article:185b95b3ae0241efb2f75ef0ed8fba8c2021-11-21T12:34:17ZImmune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma10.1038/s41467-021-26974-62041-1723https://doaj.org/article/185b95b3ae0241efb2f75ef0ed8fba8c2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-26974-6https://doaj.org/toc/2041-1723PD-1 blockade is effective for only a subset of patients with cutaneous T cell lymphomas. Here, the authors report a spatial biomarker that uses immune and cancer cell topography to predict response to PD-1 blockade in this disease.Darci PhillipsMagdalena MatusiakBelén Rivero GutierrezSalil S. BhateGraham L. BarlowSizun JiangJanos DemeterKimberly S. SmytheRobert H. PierceSteven P. FlingNirasha RamchurrenMartin A. CheeverYury GoltsevRobert B. WestMichael S. KhodadoustYoun H. KimChristian M. SchürchGarry P. NolanNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Darci Phillips
Magdalena Matusiak
Belén Rivero Gutierrez
Salil S. Bhate
Graham L. Barlow
Sizun Jiang
Janos Demeter
Kimberly S. Smythe
Robert H. Pierce
Steven P. Fling
Nirasha Ramchurren
Martin A. Cheever
Yury Goltsev
Robert B. West
Michael S. Khodadoust
Youn H. Kim
Christian M. Schürch
Garry P. Nolan
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
description PD-1 blockade is effective for only a subset of patients with cutaneous T cell lymphomas. Here, the authors report a spatial biomarker that uses immune and cancer cell topography to predict response to PD-1 blockade in this disease.
format article
author Darci Phillips
Magdalena Matusiak
Belén Rivero Gutierrez
Salil S. Bhate
Graham L. Barlow
Sizun Jiang
Janos Demeter
Kimberly S. Smythe
Robert H. Pierce
Steven P. Fling
Nirasha Ramchurren
Martin A. Cheever
Yury Goltsev
Robert B. West
Michael S. Khodadoust
Youn H. Kim
Christian M. Schürch
Garry P. Nolan
author_facet Darci Phillips
Magdalena Matusiak
Belén Rivero Gutierrez
Salil S. Bhate
Graham L. Barlow
Sizun Jiang
Janos Demeter
Kimberly S. Smythe
Robert H. Pierce
Steven P. Fling
Nirasha Ramchurren
Martin A. Cheever
Yury Goltsev
Robert B. West
Michael S. Khodadoust
Youn H. Kim
Christian M. Schürch
Garry P. Nolan
author_sort Darci Phillips
title Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
title_short Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
title_full Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
title_fullStr Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
title_full_unstemmed Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
title_sort immune cell topography predicts response to pd-1 blockade in cutaneous t cell lymphoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/185b95b3ae0241efb2f75ef0ed8fba8c
work_keys_str_mv AT darciphillips immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT magdalenamatusiak immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT belenriverogutierrez immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT salilsbhate immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT grahamlbarlow immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT sizunjiang immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT janosdemeter immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT kimberlyssmythe immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT roberthpierce immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT stevenpfling immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT nirasharamchurren immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT martinacheever immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT yurygoltsev immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT robertbwest immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT michaelskhodadoust immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT younhkim immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT christianmschurch immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
AT garrypnolan immunecelltopographypredictsresponsetopd1blockadeincutaneoustcelllymphoma
_version_ 1718418869226307584